Okay, let's tackle this question about competitive inhibition. The user wants a detailed explanation for a medical student preparing for NEET PG, USMLE, etc. First, I need to recall the core concept of competitive inhibition.

Competitive inhibition involves an inhibitor that competes with the substrate for the active site of the enzyme. The inhibitor is structurally similar to the substrate. This type of inhibition can be overcome by increasing the substrate concentration because the inhibitor and substrate are in direct competition. The key here is that the maximum velocity (Vmax) remains the same, but the apparent Michaelis constant (Km) increases because a higher substrate concentration is needed to reach half of Vmax.

Now, the question is asking which statement is not true. The correct answer is probably one that contradicts these points. Let's think about common distractors. For example, a wrong option might say that increasing substrate concentration doesn't overcome inhibition, which would be incorrect. Another might claim that Vmax decreases, which is false because Vmax stays the same in competitive inhibition. Another wrong option could suggest that the inhibitor binds to the allosteric site, which is characteristic of non-competitive inhibition.

For each incorrect option, I need to explain why it's wrong. For instance, if an option states that the inhibitor binds to the allosteric site, that's incorrect because competitive inhibitors bind to the active site. If an option says Vmax decreases, that's a mistake since Vmax remains unchanged. Also, if an option mentions that the inhibitor's effect can't be overcome by substrate, that's wrong because competitive inhibition is indeed overcome by increasing substrate.

The clinical pearl here is to remember that competitive inhibition is reversible with substrate concentration, and the key enzyme parameters are Vmax stays the same while Km increases. Students should note that in exams, they might see scenarios where they have to differentiate between competitive and non-competitive inhibition based on these parameters.

**Core Concept**
Competitive inhibition occurs when an inhibitor structurally resembles the substrate and competes for binding at the enzyme's active site. This type of inhibition increases the apparent *Km* (Michaelis constant) but leaves *Vmax* unchanged, as substrate concentration can overcome the inhibitor.

**Why the Correct Answer is Right**
In competitive inhibition, the inhibitor binds reversibly to the enzyme's active site, preventing substrate binding. Increasing substrate concentration outcompetes the inhibitor, restoring reaction rates. The *Vmax* remains unchanged because, at extremely high substrate concentrations, all enzyme active sites are occupied by substrate, overcoming inhibition. The *Km* increases due to reduced enzyme-substrate affinity.

**Why Each Wrong Option is Incorrect**
**Option A:** *States that competitive inhibition decreases Vmax.* Incorrect because Vmax remains unchanged; the enzyme can still reach maximum velocity when substrate concentration is sufficiently high.
**Option C:** *Claims the inhibitor binds irreversibly.* Incorrect as competitive inhibition is reversible; the inhibitor binds via non-covalent interactions.
**Option D:** *Suggests the inhibitor binds to an allosteric site.* Incorrect because competitive inhibitors bind directly to the active site, not allosteric regions.

**Clinical Pearl / High-Yield Fact**
Remember the "Km up, Vmax same" rule for competitive inhibition. Use the mnemonic: **"Competitor takes the active seat—needs more substrate to fill it."** Distinguish

✓ Correct Answer: D. Excess substrate do not abolish the inhibition